Literature DB >> 24900520

Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators: patent highlight.

Benjamin Blass1.   

Abstract

Entities:  

Year:  2012        PMID： 24900520      PMCID： PMC4025829          DOI： 10.1021/ml300157r

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

Review 1.  CYP17 inhibitors for prostate cancer therapy.

Authors:  Tadas S Vasaitis; Robert D Bruno; Vincent C O Njar
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-17       Impact factor: 4.292

Review 2.  Targeting CYP17: established and novel approaches in prostate cancer.

Authors:  Timothy A Yap; Craig P Carden; Gerhardt Attard; Johann S de Bono
Journal:  Curr Opin Pharmacol       Date:  2008-07-28       Impact factor: 5.547
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.